Photo of Evolve BioSystems CEO Tim Brown courtesy of Evolve.
Series C lead investors: Gates Foundation, Li Ka Shing Foundation venture arm
First outside investment: $1 million seed round in ’14
Evolve looks to penetrate Asia market, develop microbiome diagnostic test
Evolve BioSystems is gearing up to take its infant probiotic global and create new products that fight malnutrition, having scored a $40 million Series C financing led by the Bill and Melinda Gates Foundation and Horizon Ventures, Li Ka Shing ...